| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |